IBM
IBM
$231.70
+0.13%
International Business Machines Corporation (IBM) is a global technology company that provides a broad portfolio of hybrid cloud, AI, and consulting services, including its flagship watsonx AI platform and Red Hat software, to enterprise clients across 175 countries. As a legacy tech titan, IBM differentiates itself through its deep enterprise relationships, serving 95% of the Fortune 500, and its strategic focus on high-value software and services rather than consumer hardware. The current investor narrative centers on IBM's AI-driven transformation and its recent profit warning, which triggered a sharp stock decline amid concerns about software spending and the pace of AI monetization. The market is debating whether IBM's hybrid cloud and AI positioning will drive sustainable growth or if it faces structural headwinds from shifting enterprise IT budgets.…
IBM
IBM
$231.70
Related headlines
Investment Opinion: Should I buy IBM Today?
Rating: Hold. IBM's current valuation is not compelling enough to warrant a Buy, given the recent profit warning and revenue deceleration. The consensus rating is 'Buy' with an average target of $244.91, implying only 3.9% upside, which is modest. The thesis is that IBM's AI and hybrid cloud positioning provides long-term growth potential, but near-term headwinds limit upside.
Sign up to view all
IBM 12-Month Price Forecast
The AI assessment is neutral with medium confidence. IBM's AI positioning is strong, but the recent profit warning and revenue deceleration raise doubts about near-term monetization. The stock's valuation is not cheap on a forward PE basis, but the PEG ratio suggests value. If AI revenue growth accelerates in the next two quarters, the stance would upgrade to bullish. Conversely, if the company issues another warning or growth slows further, it would downgrade to bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IBM's 12-month outlook, with a consensus price target around $245.35 and implied upside of +5.9% versus the current price.
Average Target
$245.35
0 analysts
Implied Upside
+5.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$174 - $350
Analyst target range
IBM has coverage from 23 analysts, with a consensus recommendation of 'Buy' and a mean rating of 2.2 (where 1 is Strong Buy and 5 is Sell). The average target price is $244.91, implying a 3.9% upside from the current price of $235.59. The distribution shows a bullish tilt, with 13 Buy ratings, 7 Hold, and 3 Sell, indicating a moderately positive outlook. The high target of $350 suggests a 48.6% upside, while the low target of $174 implies a 26.2% downside, reflecting a wide range of outcomes. Recent actions include upgrades from JP Morgan (Overweight) and HSBC (Reduce), showing mixed sentiment, but the overall consensus remains positive, with the average target suggesting modest upside potential.
Drowning in data?
Find the real signal!
Bulls vs Bears: IBM Investment Factors
IBM presents a mixed investment case. On the bullish side, its strong AI positioning, high margins, and undervaluation on a PEG basis are compelling. However, the recent profit warning, revenue deceleration, and high debt levels are significant bearish factors. Currently, the bearish evidence is slightly stronger due to the recent negative catalysts and market underperformance. The most critical tension is whether IBM can successfully monetize its AI investments to reignite growth, which would validate the bullish thesis and drive the stock higher. If AI adoption accelerates, the stock could see substantial upside; if not, the current valuation may be too high.
Bullish
- Strong AI and Hybrid Cloud Positioning: IBM's watsonx AI platform and Red Hat software are central to its hybrid cloud strategy, serving 95% of Fortune 500 companies. This deep enterprise integration provides a durable competitive moat and a large addressable market for AI-driven transformation.
- Undervalued on PEG Ratio: With a PEG ratio of 0.35, IBM trades at a significant discount to its expected earnings growth, suggesting the market is underpricing its growth potential. This is a key value signal for investors seeking growth at a reasonable price.
- High Gross and Operating Margins: IBM's gross margin stands at 58.2% and operating margin at 18.5%, reflecting strong pricing power and operational efficiency. These margins are well above the sector average, indicating a high-quality earnings stream.
- Strong Free Cash Flow Generation: IBM generated $14.58 billion in trailing twelve-month free cash flow, providing ample capacity for dividends, debt reduction, and strategic investments. This financial flexibility supports shareholder returns and long-term growth initiatives.
Bearish
- Recent Profit Warning and Stock Plunge: IBM issued a profit warning in July 2026, causing a 25% drop in the stock price. This was driven by concerns over software spending and AI monetization, raising doubts about the company's near-term growth trajectory.
- Revenue Growth Deceleration: Revenue growth slowed from 12.1% YoY in Q4 2025 to 9.5% YoY in Q2 2026, indicating a deceleration trend. This slowdown may not justify the premium valuation and could lead to further multiple compression.
- High Debt-to-Equity Ratio: IBM's debt-to-equity ratio of 2.06 is elevated, reflecting significant leverage. This increases financial risk, especially in a rising interest rate environment, and could constrain future investments or dividend growth.
- Underperformance vs. Market: IBM's 1-year price change of -4.13% significantly lags the S&P 500's +18.56% gain. This persistent underperformance indicates negative investor sentiment and a lack of momentum, which could continue.
IBM Technical Analysis
IBM's stock is in a clear downtrend over the past year, with a 1-year price change of -4.13%, significantly underperforming the S&P 500's +18.56% gain. The current price of $235.59 sits at 71% of its 52-week range (low $199.19, high $332.46), indicating the stock is closer to its lows than highs, reflecting persistent selling pressure. This positioning suggests the market is pricing in negative sentiment, but also that the stock may be approaching oversold levels, potentially offering a value opportunity if fundamentals stabilize.
Beta
0.70
0.70x market volatility
Max Drawdown
-37.5%
Largest decline past year
52-Week Range
$199-$332
Price range past year
Annual Return
-4.1%
Cumulative gain past year
| Period | IBM Return | S&P 500 |
|---|---|---|
| 1m | +2.4% | +1.0% |
| 3m | -23.2% | +1.1% |
| 6m | -10.5% | +13.8% |
| 1y | -4.1% | +19.5% |
| ytd | -20.5% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBM Fundamental Analysis
IBM's revenue trajectory has been volatile, with Q2 2026 revenue of $15.917 billion, up 9.5% YoY from $14.541 billion in Q1 2025, but down from $19.686 billion in Q4 2025, reflecting seasonal patterns. The most recent quarter (Q2 2026) showed a 9.5% YoY growth, but the multi-quarter trend shows deceleration from Q4 2025's 12.1% growth to Q2 2026's 9.5%, indicating a slowdown. Segment-wise, Software is the largest contributor at $7.052 billion, followed by Consulting at $5.272 billion, with Infrastructure Services at $3.326 billion, but growth is being driven by software and consulting, while infrastructure remains flat. The revenue growth is positive but not accelerating, which may not justify a premium valuation.
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$14.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBM Overvalued?
Given IBM's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 26.07x, while the forward PE is 17.90x, indicating the market expects significant earnings growth, with a 31% discount between trailing and forward multiples. This gap implies the market is pricing in a substantial earnings recovery, which is supported by the PEG ratio of 0.35, suggesting the stock is undervalued relative to its growth rate. However, the forward PE of 17.90x is still above the sector average of 15x, indicating a premium that may be justified by IBM's strong margins and cash flow generation.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: IBM's high debt-to-equity ratio of 2.06 indicates significant leverage, which increases financial risk, especially with rising interest rates. The company's interest expense of $473 million in Q1 2026 is substantial, and any further rate hikes could pressure earnings. Additionally, the recent profit warning suggests potential operational challenges, with revenue growth decelerating from 12.1% to 9.5% YoY. The current ratio of 0.93 indicates potential liquidity issues, which could limit flexibility in adverse conditions. However, strong free cash flow of $14.58 billion provides a buffer, but the reliance on continued growth to justify the forward PE of 17.9x is a risk if growth stalls.
FAQ
The key risks include: 1) Financial risk from high debt-to-equity of 2.06, which could strain earnings if interest rates rise. 2) Competitive risk from AI-native companies like Pegasystems, which are winning deals with AI-driven solutions. 3) Macro risk from a potential economic slowdown, which could reduce enterprise IT spending. 4) Company-specific risk of further profit warnings or failure to monetize AI investments. The most severe risk is a prolonged revenue deceleration, which could lead to a 26% downside to the low target of $174.
The 12-month forecast is mixed. The base case, with a 50% probability, sees the stock trading around $244.91, the analyst average target, implying a 3.9% upside. The bull case, with a 25% probability, targets $280-$350, driven by AI acceleration. The bear case, also 25% probability, targets $174-$220, if growth disappoints. The most likely scenario is the base case, assuming IBM can maintain steady growth without major surprises.
IBM's valuation is mixed. The trailing PE of 26.07x is higher than the sector average, but the forward PE of 17.9x is closer to fair value. The PEG ratio of 0.35 suggests the stock is undervalued relative to its expected growth, but the growth rate is decelerating. Compared to its own history, the stock trades at a discount to its 52-week high of $332.46, but the recent decline may not be fully justified. Overall, IBM is fairly valued, with the market pricing in moderate growth but not a major AI breakthrough.
IBM is a moderate buy at current levels. The stock offers a 2.27% dividend yield and trades at a forward PE of 17.9x, which is a premium to the sector average of 15x. The average analyst target of $244.91 implies only 3.9% upside, but the high target of $350 suggests significant potential if AI monetization succeeds. However, the recent profit warning and revenue deceleration are concerns. For long-term investors with a 3-5 year horizon, IBM could be a good buy if AI growth materializes, but for short-term traders, the stock may face continued volatility.
IBM is more suitable for long-term investment due to its stable cash flows, dividend yield, and AI growth potential. The stock's beta of 0.705 indicates lower volatility than the market, making it a defensive choice. However, the recent price swings show short-term risk. For long-term investors, a minimum holding period of 3-5 years is recommended to allow AI initiatives to mature. Short-term traders may find opportunities in the volatility, but the stock's underperformance suggests limited momentum.
